DANIEL GRIFFITH ANDERSON

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Matthew Kowalsky, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by DANIEL GRIFFITH ANDERSON:

Company Role Class Num Shares Value Price $ Report Date Ownership
Sigilon Therapeutics, Inc. Director Common Stock 2,022,222 02 Jun 2021 Direct

Insider Reports Filed by DANIEL GRIFFITH ANDERSON

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SGTX Sigilon Therapeutics, Inc. 02 Jun 2021 1 -$2,000,000 4 Director 04 Jun 2021, 16:15